Alzamend Stock Analysis

The latest indifference towards the small price fluctuations of Alzamend Neuro could raise concerns from institutional investors as the firm it trading at a share price of 0.0 on very low momentum in volume. The company executives did not add any value to Alzamend Neuro investors in July. However, most investors can still diversify their portfolios with Alzamend Neuro to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently very low. The very small Stock volatility is a good signal to institutional investors with longer-term investment horizons.
Please continue to Trending Equities.

Search Stock Analysis 

 
Refresh
The Alzamend Neuro stock analysis report makes it easy to digest most publicly released information about Alzamend Neuro and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Alzamend Stock analysis module also helps to analyze the Alzamend Neuro price relationship with some important fundamental indicators such as market cap and management efficiency.

Alzamend Stock Analysis Notes

The company had not issued any dividends in recent years.

Alzamend Neuro Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Alzamend Neuro's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Alzamend Neuro or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Alzamend Neuro is not yet fully synchronised with the market data
Alzamend Neuro has some characteristics of a very speculative penny stock
Alzamend Neuro has high likelihood to experience some financial distress in the next 2 years
Alzamend Neuro has a frail financial position based on the latest SEC disclosures

Alzamend Neuro SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Alzamend Neuro prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Alzamend Neuro investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Alzamend Neuro specific information freely available to individual and institutional investors to make a timely investment decision.
28th of July 2021
Financial Statements and Exhibits. Regulation FD Disclosure
View
23rd of July 2021
Financial Statements and Exhibits. Regulation FD Disclosure
View
25th of June 2021
Unclassified Corporate Event
View
22nd of June 2021
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View

Alzamend Profitablity

Alzamend Neuro's profitability indicators refer to fundamental financial ratios that showcase Alzamend Neuro's ability to generate income relative to its revenue or operating costs. If, let's say, Alzamend Neuro is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Alzamend Neuro's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Alzamend Neuro's profitability requires more research than a typical breakdown of Alzamend Neuro's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2021
Return on Average Assets(2.13) (2.30) 
Return on Average Equity(3.56) (3.84) 
Return on Invested Capital(8.50) (9.17) 

Management Efficiency

The value of Return on Average Assets is estimated to slide to -2.3. The value of Return on Average Equity is estimated to slide to -3.84. Average Assets is expected to rise to about 2.4 M this year, although the value of Total Assets will most likely fall to about 2.7 M. Alzamend Neuro management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for 2021
Book Value per Share 0.028  0.0234 
Tangible Assets Book Value per Share 0.04  0.0386 
Tangible Asset Value2.9 M2.7 M

Alzamend Neuro Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Alzamend Neuro insiders, such as employees or executives, is commonly permitted as long as it does not rely on Alzamend Neuro's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Alzamend Neuro insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Alzamend Neuro Technical and Predictive Indicators

About Alzamend Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Alzamend Neuro stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Alzamend shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Alzamend Neuro. By using and applying Alzamend Stock analysis, traders can create a robust methodology for identifying Alzamend entry and exit points for their positions.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Alzamend Neuro to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Diagnostics Now

   

Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
All  Next Launch Module
Please continue to Trending Equities. Note that the Alzamend Neuro information on this page should be used as a complementary analysis to other Alzamend Neuro's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Tools for Alzamend Stock

When running Alzamend Neuro price analysis, check to measure Alzamend Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alzamend Neuro is operating at the current time. Most of Alzamend Neuro's value examination focuses on studying past and present price action to predict the probability of Alzamend Neuro's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Alzamend Neuro's price. Additionally, you may evaluate how the addition of Alzamend Neuro to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go